PRINCIPAL FINANCIAL GROUP INC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 128 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$29,000
-34.1%
10,811
+7.1%
0.00%
Q4 2021$44,000
-66.4%
10,099
-60.6%
0.00%
Q3 2021$131,000
+37.9%
25,601
+71.2%
0.00%
Q2 2021$95,000
-47.5%
14,956
-36.1%
0.00%
Q1 2021$181,000
+129.1%
23,399
+94.0%
0.00%
Q4 2020$79,000
-76.9%
12,063
-34.7%
0.00%
Q3 2018$342,000
-17.0%
18,480
+2.6%
0.00%
Q2 2018$412,00018,0100.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
BVF INC/IL 5,803,700$25,130,0000.91%
Altium Capital Management LP 663,800$2,874,0000.79%
Rubric Capital Management LP 2,406,449$10,420,0000.49%
RTW INVESTMENTS, LP 6,029,700$26,109,0000.38%
Orbimed Advisors 3,214,509$13,919,0000.18%
TANG CAPITAL MANAGEMENT LLC 152,345$660,0000.13%
PLATINUM INVESTMENT MANAGEMENT LTD 980,085$4,244,0000.12%
Point72 Asset Management, L.P. 6,303,025$27,292,0000.11%
Sender Co & Partners, Inc. 40,720$176,0000.09%
Manteio Capital LLC 15,067$65,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders